Novo Nordisk A/S ADR buy melinda
Start price
17.01.17
/
50%
€32.79
Target price
24.04.17
€33.37
Performance (%)
2.29%
End price
24.04.17
€32.94
Summary
This prediction ended on 24.04.17 with a price of €32.94. The BUY prediction by melinda finished with a performance of 2.29%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | -3.095% | -3.095% | -60.485% | -67.698% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
Comments by melinda for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk (NVO) erhält FDA Orphan-Drug-Status von Diabetes Combo
folgen
Stopped prediction by melinda for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€158.50
14.05.23
14.05.23
€165.00
14.05.24
14.05.24
-22.71%
15.05.24
15.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€43.06
01.09.17
01.09.17
€49.61
29.12.17
29.12.17
13.28%
29.12.17
29.12.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€47.74
01.09.17
01.09.17
€55.00
29.12.17
29.12.17
13.28%
29.12.17
29.12.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€37.95
06.07.17
06.07.17
€45.10
29.08.17
29.08.17
11.71%
29.08.17
29.08.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€42.07
06.07.17
06.07.17
€50.00
29.08.17
29.08.17
11.71%
29.08.17
29.08.17